Search Results - "P. Papakostas"

Body composition analysis for discrimination of prolonged hospital stay in colorectal cancer surgery patients by Tsaousi, G., Kokkota, S., Papakostas, P., Stavrou, G., Doumaki, E., Kotzampassi, K.

“…We aimed to ascertain the implementation of body composition assessment, by means of fat‐free mass index (FFMI), fat mass index (FMI) and presence of…”
Get full text

Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer by Razis, E., Bobos, M., Kotoula, V., Eleftheraki, A. G., Kalofonos, H. P., Pavlakis, K., Papakostas, P., Aravantinos, G., Rigakos, G., Efstratiou, I., Petraki, K., Bafaloukos, D., Kostopoulos, I., Pectasides, D., Kalogeras, K. T., Skarlos, D., Fountzilas, G.

“…Trastuzumab (T) is effective in metastatic breast cancer (MBC) with HER2 overexpression and/or amplification, but resistance to T develops in a significant…”
Get full text

randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer by Bamias, Aristotelis, Karina, M, Papakostas, P, Kostopoulos, I, Bobos, M, Vourli, G, Samantas, E, Christodoulou, Ch, Pentheroudakis, G, Pectasides, D, Dimopoulos, M. A, Fountzilas, G

“…The optimal adjuvant treatment for gastric cancer remains controversial. We compared the efficacy of a docetaxel and platinum adjuvant chemotherapy regimen, in…”
Get full text

Docetaxel and Cisplatin With Granulocyte Colony-Stimulating Factor (G-CSF) Versus MVAC With G-CSF in Advanced Urothelial Carcinoma: A Multicenter, Randomized, Phase III Study From the Hellenic Cooperative Oncology Group by BAMIAS, A, ARAVANTINOS, G, PAPAKASTAS, P, GIKA, D, KOUROUSIS, C, KOUTRAS, A, PAPADIMITRIOU, C, BAMIAS, C, KOSMIDIS, P, DIMOPOULOS, M. A, DELIVELIOTIS, C, BAFALOUKOS, D, KALOFONOS, C, XIROS, N, ZERVAS, A, MITROPOULOS, D, SAMANTAS, E, PECTASIDES, D

“…The combination of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) represents the standard regimen for inoperable or metastatic urothelial cancer,…”
Get full text

Real-world efficacy and toxicity data of paclitaxel and ramucirumab compared with other treatment regimens in patients with advanced gastric cancer by E. Fountzilas, J. Souglakos, J. Alafis, K. Dadouli, A. Koumarianou, N. Tsoukalas, A. Nikolaidi, D. Mauri, M. Karagianni, A. Anna, A. Psyrri, G. Rigakos, A. Avgerinos, M. Theochari, D. Pectasides, G. Oikonomopoulos, A. Vagionas, P. Papakostas, A. Christopoulou, G. Fountzilas, Z. Saridaki

“…Background: The superiority of paclitaxel/ramucirumab over alternative therapeutic regimens in patients with gastric cancer has yet to be defined. Our aim was…”
Get full text

Predictive significance of tumour angiogenic and anti-angiogenic VEGF-A splice variants in patients with metastatic colorectal cancer by Pentheroudakis, G., Kotoula, V., Koliou, G.-A., Papadopoulou, K., Samantas, E., Makatsoris, T., Karavasilis, V., Mauri, D., Efstratiou, I., Bafaloukos, D., Papakostas, P., Psyrri, A., Papatsibas, G., Zarkavelis, G., Goussia, A., Bompolaki, I., Oikonomopoulos, G., Christopoulou, A.N., Pectasides, D.G., Fountzilas, G.

Get full text

Cyclin D1 differential activation and its prognostic impact among advanced breast cancer patients treated with trastuzumab by Mountzios, G., Kotoula, V., Koliou, G.-A., Papadopoulou, K., Lazaridis, G., Christodoulou, C., Pentheroudakis, G., Skondra, M., Koutras, A., Linardou, H., Razis, E., Papakostas, P., Chrisafi, S., Aravantinos, G., Nicolaou, I., Goussia, A., Kalogeras, K.T., Pectasides, D.G., Fountzilas, G.

Get full text

Prognostic implications of mismatch repair deficiency in patients with early-stage colorectal and endometrial cancer by Fountzila, E., Kotoula, V., Pentherdoudakis, G., Manousou, K., Vrettou, E., Poulios, C., Papadimitriou, C., Raptou, G., Pectasides, E., Polychronidou, G., Karayannopoulou, G., Chrisafi, S., Papakostas, P., Makatsoris, T., Psyrri, A., Samantas, E., Bobos, M., Christodoulou, C., Pectasides, D.G., Fountzilas, G.

Get full text

Prevention and prophylaxis of thrombosis in cancer patients by Tsoukalas, N.G., Papakotoulas, P., Christopoulou, A.N., Ardavanis, A., Koumakis, G., Papandreou, C., Papatsimpas, G., Papakostas, P., Andreadis, C., Aravantinos, G., Ziras, N., Kalofonos, H., Samantas, E., Sougleri, M., Makrantonakis, P., Pentheroudakis, G., Athanasiadis, A., Bournakis, E., Varthalitis, I.I., Boukovinas, I.

Get full text

Actionable mutations and overall survival in 3,211 patients with cancer: The Hellenic cooperative oncology group precision medicine initiative by Fountzila, E., Kotoula, V., Koliou, G.-A., Giannoulatou, E., Gogas, H., Papadimitriou, C., Tikas, I.S., Papadopoulou, K., Zagouri, F., Christodoulou, C., Koutras, A., Razis, E., Papakostas, P., Samantas, E., Aravantinos, G., Psyrri, A., Pectasides, D.G., Futreal, A., Tsimberidou, A.-M., Fountzilas, G.

Get full text

Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: A Hellenic Cooperative Oncology Group (HeCOG) study by Koutras, A K, Kalogeras, K T, Dimopoulos, M-A, Wirtz, R M, Dafni, U, Briasoulis, E, Pectasides, D, Gogas, H, Christodoulou, C, Aravantinos, G, Zografos, G, Timotheadou, E, Papakostas, P, Linardou, H, Razis, E, Economopoulos, T, Kalofonos, H P, Fountzilas, G

“…The aim of the study was to evaluate the prognostic ability of the transcriptional profiling of the HER family genes in early breast cancer, as well as to…”
Get full text

2336 Clinical and therapeutic aspects of neuroendocrine tumors: The Greek NET Registry by Koumarianou, A, Nikou, G, Dimitroulopoulos, D, Alexandrakis, G, Papakostas, P, Vaslamatzis, M, Kaldrymidis, P, Markoussis, V, Pazaitou-Panayiotou, K

Get full text

Economic Evaluation of NAB-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone for The Management of Metastatic Pancreatic Cancer in Greece by Fragoulakis, V, Papakostas, P, Pentheroudakis, G, Dervenis, C, Maniadakis, N

Get full text

A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: A Hellenic Cooperative Oncology Group study by Fountzilas, G., Dafni, U., Dimopoulos, M. A., Koutras, A., Skarlos, D., Papakostas, P., Gogas, H., Bafaloukos, D., Kalogera-Fountzila, A., Samantas, E., Briasoulis, E., Pectasides, D., Maniadakis, N., Matsiakou, F., Aravantinos, G., Papadimitriou, C., Karina, M., Christodoulou, C., Kosmidis, P., Kalofonos, H. P.

“…Background Effective anthracycline-free combinations need to be evaluated in metastatic breast cancer (MBC), due to the increased number of patients treated…”
Get full text

randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer by Fountzilas, G, Dafni, U, Dimopoulos, M. A, Koutras, A, Skarlos, D, Papakostas, P, Gogas, H, Bafaloukos, D, Kalogera-Fountzila, A, Samantas, E, Briasoulis, E, Pectasides, D, Maniadakis, N, Matsiakou, F, Aravantinos, G, Papadimitriou, C, Karina, M, Christodoulou, C, Kosmidis, P, Kalofonos, H. P

“…Background Effective anthracycline-free combinations need to be evaluated in metastatic breast cancer (MBC), due to the increased number of patients treated…”
Get full text

1813 Interaction of TP53 mutations with trastuzumab in HER2-positive patients with operable breast cancer by Kotoula, V, Zagouri, F, Alexopoulou, Z, Gogas, H, Lakis, S, Pentheroudakis, G, Bobos, M, Papadopoulou, K, Tsolaki, E, Skondra, M, Karavasilis, V, Koutras, A, Chrisafi, S, Christodoulou, C, Papakostas, P, Linardou, H, Markopoulos, C, Zografos, G, Samantas, E, Fountzilas, G

Get full text

Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group by Fountzilas, G., Skarlos, D., Dafni, U., Gogas, H., Briasoulis, E., Pectasides, D., Papadimitriou, C., Markopoulos, C., Polychronis, A., Kalofonos, H. P., Siafaka, V., Kosmidis, P., Timotheadou, E., Tsavdaridis, D., Bafaloukos, D., Papakostas, P., Razis, E., Makrantonakis, P., Aravantinos, G., Christodoulou, C., Dimopoulos, A.-M.

“…Purpose: The aim of this study was to explore the effect of dose-dense sequential chemotherapy with or without paclitaxel primarily on disease-free survival…”
Get full text

Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases by Christodoulou, C., Bafaloukos, D., Kosmidis, P., Samantas, E., Bamias, A., Papakostas, P., Karabelis, A., Bacoyiannis, C., Skarlos, D. V.

“…Purpose: To determine the efficacy, tolerability, and safety of temozolomide in heavily pretreated patients with solid tumors and brain metastases. Patients…”
Get full text

Cytokine modulation by endothelin-1 and possible therapeutic implications in systemic sclerosis by Giordano, N, Papakostas, P, Pecetti, G, Nuti, R

“…Systemic sclerosis (SSc), also known as scleroderma, is an autoimmune disorder characterized by a progressive fibrosis which involves skin and internal organs,…”
Get more information

Pancreatic resection for renal cell carcinoma metastasis: An exceptionally rare coexistence by Boussios, Stergios, MD, PhD candidate, Zerdes, Ioannis, MD, Batsi, Rania, MD, Papakostas, Vasilios P., MD, Seraj, Esmeralda, MD, Pentheroudakis, George, MD, PhD, Glantzounis, George K., MD, PhD

“…Highlights • RCC is the predominant primary tumor for isolated pancreatic metastases. • Pancreatic metastases from RCC generally tends to slow growth and…”
Get full text